
Please try another search
Shanghai Rightongene Biotechnology Co., Ltd. engages in the research and development, production, and sale of molecular diagnosis of infectious diseases. It provides self-operated reagents, purchased preparations, scientific research services, and testing services for blood diseases, solid tumors, infectious diseases and lymphoma. The company was founded in 2012 and is based in Shanghai, China.
Name | Age | Since | Title |
---|---|---|---|
Yanbo Sun | 37 | 2022 | Director |
Shangxian Gao | 67 | 2018 | Director |
Hui Xiong | 52 | 2018 | Chairman & GM |
Guiying Zhao | 70 | 2018 | Independent Director |
Xuewei Yuan | 52 | 2018 | Independent Director |
Yunhang Li | 36 | 2019 | Chairman of the Supervisory Board |
Jun Xiong | 48 | 2018 | Deputy GM & Director |
Yue Xiao | 37 | 2023 | Supervisor |
Jing Huang | 35 | 2024 | Employee Representative Supervisor |
Guangce Jiang | 54 | 2023 | Independent Director |
Liangying Cheng | 49 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review